Sites of action of thyrotropin-releasing hormone on central nervous system neurons revealed by expression of the immediate-early gene c-fos in the rat

Neuroscience

Volumn 95, Issue 4, 1999, Pages 1167-1177

  Otake, K ^a   Nakamura, Y ^a  

^a Dept Syst Neurosci Tokyo Med D ^*  (Japan)

Author keywords

Antipsychotic drugs; Behavior; c fos; Medial prefrontal cortex; Nucleus accumbens; Thyrotropin releasing hormone

Indexed keywords

PROTEIN C FOS; PROTIRELIN; PROTIRELIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN REGION; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; HIPPOCAMPUS; IMMEDIATE EARLY GENE; IMMUNOREACTIVITY; MALE; NERVE CONDUCTION; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ANIMALS; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION; GENES, FOS; INJECTIONS, INTRAVENTRICULAR; MALE; NEURONS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATION, ARTIFICIAL; THYROTROPIN-RELEASING HORMONE;

EID: 0033405383     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00519-9     Document Type: Article

References (59)

1. Bandler R., Carrive P. and Zhang S. P. (1991) Integration of somatic and autonomic reactions within the midbrain periaqueductal grey: viscerotopic, somatotopic and functional organization. In Progress in Brain Research (ed. Holstege G.), Vol. 87, pp. 269-305. Elsevier, Amsterdam.
2. Boler R.M., Enzmann F., Folkers K., Bowers C.Y., Shally A.V. The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochem. biophys. Res. Commun. 37:1969;705-710.
3. Breese G.R., Cott J.M., Cooper B.R., Prange A.J., Lipton M.A., Plotnikoff N.P. Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally active drugs. J. Pharmac. exp. Ther. 193:1975;11-22.
4. Brown M.R. Thyrotropin-releasing factor: a putative CNS regulator of the autonomic nervous system. Life Sci. 28:1981;1789-1795.
5. Brownstein M.J., Palkovits M., Saavedra J.M., Bassiri R.M., Utiger R.D. Thyrotropin-releasing hormone in specific nuclei of rat brain. Science. 185:1974;267-269.
6. Bullitt E. Expression of c-fos-like protein as a marker for neuronal activity following noxious stimualtion in the rat. J. comp. Neurol. 296:1990;517-530.
7. 2. C. r. hebd Séanc. Acad. Sci., Paris. 269:(2):1969;1870-1873.
8. Burt D. R. and Sharif N. A. (1990) TRH recepors. In Handbook of Chemical Neuroanatomy (eds Bjorklund A., Hokfelt T. and Kuhar M. J.), Vol. 9, pp. 477-503. Elsevier, Amsterdam.
9. Ceccatelli S., Villar M.J., Goldstein M., Hokfelt T. Expression of c-fos immunoreactivity in transmitter-characterized neurons after stress. Proc. natn. Acad. Sci. U.S.A. 86:1989;9569-9573.
10. De la Pena P., Delgado L.M., Del Camino D., Barros F. Two isoforms of the thyrotropin-releasing hormone receptor generated by alternative splicing have indistinguished functional properties. J. biol. Chem. 267:1992;25703-25708.
11. Deutch A.Y. Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease. J. neural Transm. 91:1993;197-221.
12. Deutch A.Y., Lee M.C., Iadarola M. Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: the nucleus accumbens shell as a locus of antipsychotic action. Molec. cell. Neurosci. 3:1992;332-341.
13. Dragunow M., Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J. Neurosci. Meth. 29:1989;265-269.
14. Duthie S.M., Taylor P.L., Eidne K.A. Characterization of the mouse thyrotropin-releasing hormone receptor gene: an exon corresponds to a deletion in the rat. J. molec. Endocrinol. 11:1993;141-149.
15. Dyer R.G., Dyball R.E.J. Evidence for a direct effect of LRF and TRF on single unit activity in the rostal hypothalamus. Nature. 252:1974;486-488.
16. Ennis M., Rizvi T.A., Shipley M.T., Behbehani M.M., Smith D., Van Bockstaele E.J., Luppi P., Aston-Jones G. Projections from the periaqueductal gray (PAG) to the periambigual area: relation to vagal input neurons. Soc. Neurosci. Abstr. 17:1991;611.
17. Graybiel A.M., Mortalla R., Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. natn. Acad. Sci. U.S.A. 87:1990;3915-3934.
18. Griffiths E.C. Thyrotropin-releasing hormone: endocrine and central effects. Psychoneuroendocrinology. 10:1985;225-235.
19. Herkenham M. The connections of the nucleus reuniens thalami: evidence for a direct thalamo-hippocampal pathway in the rat. J. comp. Neurol. 177:1978;588-610.
20. Herkenham M. (1986) New perspectives on the organization and evolution of nonspecific thalamocortical projections. In Cerebral Cortex (eds Jones E. G. and Peters A.), Vol. 5, pp. 403-445. Plenum, New York.
21. Horger B.A., Elsworth J.D., Roth R.H. Selective increase in dopamine utilization in the shell subdivision of the nucleus accumbens by the benzodiazepine inverse agonist FG7142. J. Neurochem. 65:1995;770-774.
22. Horita A., Carino M.A., Lai H. Pharmacology of thyrotropin releasing hormone. A. Rev. Pharmac. Toxicol. 26:1986;311-332.
23. Hunt S.P., Pini A., Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature. 328:1987;632-634.
24. Inanaga K., Nakano T., Nagata T. Behavioral effects of protirelin in schizophrenia. Archs gen. Psychiat. 35:1978;1011-1014.
25. Jackson I.M.D., Reichlin S. Thyrotropin-releasing hormone (TRH): distribution in hypothalamus and extrahypothalamic brain tissue of mammalian and submammalian chordates. Endocrinology. 95:1974;854-862.
26. Jaskiw G.E., Weiberger D.R. Dopamine and schizophrenia - a cortically corective perspective. Sem. Neurosci. 4:1992;179-188.
27. Kalivas P.W., Duffy P. Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res. 675:1995;325-328.
28. Kastin A.J., Ehrensing R.H., Schalch D.S., Anderson M.S. Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone. Lancet. 2:1972;740-742.
29. King D., Zigmond M.J., Finlay J.M. Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell. Neuroscience. 77:1997;141-153.
30. LeDoux J.E., Ruggiero D.A., Reis D.J. Projections to the subcortical forebrain from anatomically defined regions of the medial geniculate body in the rat. J. comp. Neurol. 242:1985;182-213.
31. Lovick T.A. Integrated activity of cardiovascular and pain regulatory systems: role in adaptive behavioral responses. Prog. Neurobiol. 40:1993;631-644.
32. Marsden C.A., Bennet G.W., Fone K.C.F., Johnson J.V. Functional interactions between TRH and 5-hydroxytryptamine (5-HT) and proctolin in rat brain and spinal cord. Ann. N.Y. Acad. Sci. 553:1989;121-134.
33. Merchant K.M., Dorsa D.M. Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics. Proc. natn. Acad. Sci. U.S.A. 90:1993;3447-3451.
34. Metcalf G., Dettmar P.W. Is thyrotropin-releasing hormone an endogenous ergotropic substance in the brain? Lancet. 1:1981;586-589.
35. Morgan J.I., Cohen D.R., Hempstead J.L., Curran T. Mapping patterns of c-fos expression in the central nervous system after seizure. Science. 237:1987;192-197.
36. Morgan J.I., Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. A. Rev. Neurosci. 14:1991;421-451.
37. Mtui E.P., Anwar M., Gomez R., Reis D.J., Ruggiero D.A. Projections from the nucleus tractus solitarii to the spinal cord. J. comp. Neurol. 337:1993;231-252.
38. Ohtake T., Yamada H. Efferent connections of the nucleus reuniens and the rhomboid nucleus in the rat. Neurosci. Res. 6:1989;556-568.
39. Oliver C., Eskay R.L., Ben-Jonathan N., Porter J.C. Distribution and concentration of TRH in the rat brain. Endocrinology. 95:1974;540-546.
40. Otake K., Nakamura Y. Sites of actions of thyrotropin-releasing factor on CNS neurons revealed by expression of the immediate-early gene c-fos in the rat. Neurosci. Res. 22:(Suppl.):1998;S70.
41. Paxinos G. and Watson C. (1998) The Rat Brain in Stereotaxic Coordinates, 4th edn. Academic, Orlando, FL.
42. Plotnikoff N.P., Prange A.J. Jr., Breese G.R., Anderson M.S., Wilson I.C. Thyrotropin releasing hormone: enhancement of DOPA activity by a hypothalamic hormone. Science. 78:1972;417-418.
43. Prange A.J.J., Utiger R.D. What does brain thyrotropin-releasing hormone do? New Engl. J. Med. 305:1981;1089-1090.
44. Prange Jr. A. J., Wilson I. C., Breese G. R. and Lipton M. A. (1975) Behavioral effects of hypothalamic releasing hormones in animals and men. In Progress in Brain Research (eds Gispen W. H., Van Wimersma-Greidanus T. B., Bohus B. and de Wied D.), Vol. 42, pp. 1-9. Elsevier, Amsterdam.
45. Prange A.J. Jr., Wilson I.C., Lala P.P., Alltop L.H., Breese G.R. Effects of thyrotropin-releasing hormone in depression. Lancet. 2:1972;999-1002.
46. Renaud L.P., Martin J.B. Thyrotropin releasing hormone (TRH): depressant action on central neuronal activity. Brain Res. 86:1975;150-154.
47. Renaud L.P., Martin J.B., Brazeau P. Depressant action of TRH, LH-RH and somatostatin on activity of central neurones. Nature. 225:1975;233-235.
48. Rocha M.J., Herbert H. Effects of anesthetics on Fos protein expression in autonomic brain nuclei related to cardiovascular regulation. Neuropharmacology. 36:1997;1779-1781.
49. Ruggiero D. A., Gomez R. E., Cravo S. L., Mtui E., Anwar M. and Reis D. J. (1991) The rostral ventrolateral medulla: anatomical substrates of cardiopulmonary integration. In Cardiorespiratory and Motor Coordination. (eds Koepchen H.-P. and Huopaniemi T.), pp. 89-102. Springer-Verlag, Berlin, Heidelberg, New York.
50. Sagar S.M., Sharp F.R., Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science. 240:1988;1328-1331.
51. Satoh T., Feng P., Wilber J.F. A truncated isoform of the thyrotropin-releasing hormone receptor is expressed in the central nervous system as well as in the pituitary gland. Molec. Brain Res. 20:1993;353-356.
52. Senba E., Matsunaga K., Tohyama M., Noguchi K. Stress-induced c-fos expression in the rat brain: activation mechanism of sympathetic pathway. Brain Res. Bull. 31:1993;329-344.
53. Sharif N.A. Quantitative autoradiography of TRH receptors in descrete brain regions of different mammlian species. Ann. N.Y. Acad. Sci. 553:1989;147-175.
54. Wilkinson L.S. The nature of interactions involving prefrontal and striatal dopamine systems. J. Psychopharmac. 11:1997;143-150.
55. Winokur A., Beckman A.L. Effects of thyrotropin releasing hormone, norepinephrine and acetylcholine on the activity of neurons in the hypothalamus, septum and cerebral cortex of the rat. Brain Res. 150:1978;205-209.
56. Winokur A., Davis R., Utiger R.D. Subcellular distribution of thyrotropin-releasing hormone (TRH) in rat brain and hypothalamus. Brain Res. 120:1977;423-434.
57. Wouterlood F.G., Saldana E., Witter M.P. Projection from the nucleus reuniens thalami to the hippocampal region: light and electron microscopic tracing study in the rat with the anterograde tracer Phaseolus vulgaris-leucoagglutinin. J. comp. Neurol. 296:1990;179-203.
58. Zahm D.S., Zaborszky L., Alheid G.F., Heimer L. The ventral striato-pallidothalamic projection: II The ventral pallidothalamic link. J. comp. Neurol. 255:1987;592-605.
59. Zilles K. (1990) Cortex. In The Human Nervous System (ed. Paxinos G.), pp. 757-802. Academic, San Diego, CA.